Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection
NCT01602614
·
clinicaltrials.gov ↗
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Cytomegalovirus Infections
Sponsor
University of Alabama at Birmingham